Cargando…

Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer

A promising new strategy for cancer therapy is to target the autophagic pathway. However, comprehensive characterization of autophagy genes and their clinical relevance in cancer is still lacking. Here, we systematically characterized alterations of autophagy genes in multiple cancer lines by analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Xin-Yue, Jiang, Yang, Li, Ming-Qi, Han, Peng, Liu, Yan-Long, Cui, Bin-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977699/ https://www.ncbi.nlm.nih.gov/pubmed/31896739 http://dx.doi.org/10.18632/aging.102607

Ejemplares similares

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
por: Huang, Changhao, et al.
Publicado: (2020)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

The rara requiem
por: Bussotti, Sylvano
Publicado: (1993)

The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
por: Allen, Joshua E., et al.
Publicado: (2013)

PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer
por: Wang, Huanan, et al.
Publicado: (2015)

Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice
por: Wartman, Lukas D., et al.
Publicado: (2012)

Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells
por: Kim, Eun-Ji, et al.
Publicado: (2018)

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
por: Allen, Joshua E., et al.
Publicado: (2013)

Jardín de flores raras /
por: Caro Baroja, Julio
Publicado: (1993)

Wanted—A Rara Avis
Publicado: (1871)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

PML-RARA mutations confer varying arsenic trioxide resistance
por: Bai, Dong-Mei, et al.
Publicado: (2016)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
por: Meng, Xiaomin, et al.
Publicado: (2018)

Enfermedades raras : ciencia y realidad de la rareza en medicina /
por: Palau, Francesc
Publicado: (2020)

Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
por: Ma, Yongchen, et al.
Publicado: (2018)

Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis
por: Gao, Su-Jie, et al.
Publicado: (2021)

Caos, fractales y cosas raras
por: Braun, Eliezer, 1949-
Publicado: (1996)

Largas filas de gente rara /
por: Boone, Luis Jorge, 1977-
Publicado: (2012)

MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA
por: Tombolan, Lucia, et al.
Publicado: (2015)

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
por: Wang, Chenyu, et al.
Publicado: (2018)

KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer
por: Zheng, Yu, et al.
Publicado: (2023)

Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
por: Bommer, Ulrich-Axel, et al.
Publicado: (2017)

Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p in vitro
por: Wang, Chen, et al.
Publicado: (2020)

Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia
por: Kim, Min Jin, et al.
Publicado: (2012)

GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS Axis in hepatocellular carcinoma
por: Gu, Yan-jiao, et al.
Publicado: (2015)

Nevus sebáceo cerebriforme: uma rara apresentação
por: da Cunha Filho, Roberto Rheingantz, et al.
Publicado: (2015)

EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
Publicado: (2023)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

HNRNPC-RARA Fusion Gene in a Case with Acute Promyelocytic Leukemia Lacking PML-RARA Rearrangement Presenting with Abundant Hemophagocytosis
por: Tan, Jing, et al.
Publicado: (2023)

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022)

PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis
por: Luo, Zhuhe, et al.
Publicado: (2022)

Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis
por: Iacovides, Demetris, et al.
Publicado: (2018)

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
por: Nagata, M, et al.
Publicado: (2011)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

Konjac glucomannan reverses multi-drug resistance of HepG2/5-FU cells by suppressing AKT signaling and increasing p53 expression
por: Chen, Bin, et al.
Publicado: (2020)

First Case of Topical 5-FU Therapy for Cutaneous Metastasis in a Patient with Colon Cancer
por: Ahmed, Gulrayz, et al.
Publicado: (2020)

Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling
por: Gao, Jinfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l7nfs2jga921f88ekn8gog651a